Diede van Ens

4PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Energy generation, conversion and storage (excl. chemical and electrical)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 20, 2023
Human CD34<sup>+</sup>-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8<sup>+</sup> T cell and NK cell responses in vitro and in vivo.

Jesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman

|May 16, 2022
Actomyosin contractility requirements and reciprocal cell-tissue mechanics for cancer cell invasion through collagen-based channels.

Lianne Beunk, Gert-Jan Bakker, Diede van Ens

|Apr 02, 2021
Clinically applicable CD34<sup>+</sup>-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.

Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir

|Jun 13, 2020
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity.

Diede van Ens, Charlotte M Mousset, Tim J A Hutten

Pageof 1

Frequent Collaborators

3 joint publications

Anniek B van der Waart

3 joint publications

Willemijn Hobo

2 joint publications

Harry Dolstra

2 joint publications

Jesper van Eck van der Sluijs